We are live on ! Find out more
SRNE

Sorrento Therapeutics, Inc.
SRNE

Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

2 hedge funds and large institutions have $6 invested in Sorrento Therapeutics, Inc. in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $4 → $6 (+$2)

50% less funds holding

Funds holding: 4 → 2 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SRNE Hedge Fund Activity: Q2 2025 in Review

2 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q2 2025, worth a combined $6 — up 50% from $4 a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SRNE and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 2 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q2 2025, down from 4 in Q1 2025.
  • Funds reported $6 of Sorrento Therapeutics, Inc. stock for Q2 2025, up 50% quarter-over-quarter.
  • 1 fund opened new Sorrento Therapeutics, Inc. positions in Q2 2025 and 2 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q2 2025.